Ana is a molecular biologist with a passion for discovery and communication. As a science writer, she looks for connecting the public, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
Use of disease-modifying anti-rheumatic drugs (DMARDs) before becoming pregnant does not increase the risk of miscarriage or birth defects in ... Read more
Ultrasound imaging with power Doppler ultrasound is not a useful method to detect active arthritis in the joints that connect jawbones to ... Read more
Therapy with Actemra (tocilizumab) yields high survival rates in patients with hard-to-treat polyarticular juvenile idiopathic arthritis (pJIA), and enables many patients ... Read more
Engaging children with juvenile idiopathic arthritis in shared decision-making with their doctors helps them better understand their disease and enhances their ... Read more
New guidelines were released by the American College of Rheumatology (ACR) and the Arthritis Foundation (AF) to provide orientation to doctors ... Read more
Treatment with Orencia (abatacept) is well-tolerated and effective in managing disease activity in children with polyarticular juvenile idiopathic arthritis (JIA), according ... Read more
Checking for blood levels of a small protein called CXCL9 can be a valuable biomarker for detecting macrophage activation syndrome (MAS), a potentially ... Read more
